Target intelligence / Profile preview

Influenza Virus Endonuclease Domain (PA-Nter)

Target
PA-Nter
Molecular classification
Enzyme, Nuclease, PD-(D/E)XK nuclease superfamily
01

Overview

The influenza virus endonuclease domain is an essential subdomain of the viral RNA-dependent RNA polymerase complex. It is located within the N-terminal domain of the PA subunit and is responsible for cleaving host pre-mRNAs to generate primers required for viral mRNA synthesis, a process known as "cap-snatching." This activity is crucial for the transcription and replication of the viral genome and makes the endonuclease domain a highly attractive target for antiviral drug development. The active site contains conserved residues that coordinate two divalent metal ions (typically manganese or magnesium), which are essential for catalytic activity. Small molecule inhibitors, such as L-742,001 and baloxavir marboxil, can bind directly to this endonuclease active site. Resistance mutations map directly within this region.

Other names
PA N-terminal domainPANPA endonuclease
02

Mechanism of action

Inhibition of endonuclease activity, preventing viral mRNA synthesis

03

Biological functions

Viral mRNA synthesisCap-snatchingPre-mRNA cleavage
04

Disease associations

InfectionInfluenza
05

Safety considerations

Resistance mutations (e.g., T20A, I38T, E119D) can reduce inhibitor binding.
06

Interacting drugs

L-742,001

1 more in the full profile.

Beyond the preview

Go deeper on Influenza Virus Endonuclease Domain (PA-Nter).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza Virus Endonuclease Domain (PA-Nter).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call